These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10355805)

  • 1. The effect of botulinum toxin A on gastrocnemius length: magnitude and duration of response.
    Eames NW; Baker R; Hill N; Graham K; Taylor T; Cosgrove A
    Dev Med Child Neurol; 1999 Apr; 41(4):226-32. PubMed ID: 10355805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Change of dynamic gastrocnemius and soleus muscle length after block of spastic calf muscle in cerebral palsy.
    Bang MS; Chung SG; Kim SB; Kim SJ
    Am J Phys Med Rehabil; 2002 Oct; 81(10):760-4. PubMed ID: 12362116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional outcome of botulinum toxin injection of gastrocnemius and adductors in spastic hemiplegic cerebral palsied children.
    Ibrahim AI; Hawamdeh ZM; Al-Qudah AA
    Eura Medicophys; 2007 Mar; 43(1):13-20. PubMed ID: 17021584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in Muscle Mass after Botulinum Toxin Injection in Children with Spastic Hemiplegic Cerebral Palsy.
    Lee D; Kim J; Oh JY; Han MH; Kim DY; Kang JH; Jang DH
    Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33919735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No change in calf muscle passive stiffness after botulinum toxin injection in children with cerebral palsy.
    Alhusaini AA; Crosbie J; Shepherd RB; Dean CM; Scheinberg A
    Dev Med Child Neurol; 2011 Jun; 53(6):553-8. PubMed ID: 21574991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety profile of incobotulinum toxin A [Xeomin(®)] in gastrocnemious muscles injections in children with cerebral palsy: Randomized double-blind clinical trial.
    Carraro E; Trevisi E; Martinuzzi A
    Eur J Paediatr Neurol; 2016 Jul; 20(4):532-7. PubMed ID: 27177451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum Toxin Type A Injection for Spastic Equinovarus Foot in Children with Spastic Cerebral Palsy: Effects on Gait and Foot Pressure Distribution.
    Choi JY; Jung S; Rha DW; Park ES
    Yonsei Med J; 2016 Mar; 57(2):496-504. PubMed ID: 26847306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative evaluation for spasticity of calf muscle after botulinum toxin injection in patients with cerebral palsy: a pilot study.
    Lin YC; Lin IL; Chou TF; Lee HM
    J Neuroeng Rehabil; 2016 Mar; 13():25. PubMed ID: 26969526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin for spasticity in children with cerebral palsy: a comprehensive evaluation.
    Bjornson K; Hays R; Graubert C; Price R; Won F; McLaughlin JF; Cohen M
    Pediatrics; 2007 Jul; 120(1):49-58. PubMed ID: 17606561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin injection of the subscapularis muscle.
    Unlu E; Sen T; Umay E; Bal B; Elhan A; Cakci A
    J Clin Neurosci; 2010 Oct; 17(10):1265-6. PubMed ID: 20591673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of physical therapy and anti-botulinum toxin antibody on the efficacy of botulinum toxin-A injections in children with spastic cerebral palsy.
    Jang DH; Sung IY
    Dev Neurorehabil; 2014 Dec; 17(6):414-9. PubMed ID: 25372070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spread of botulinum neurotoxin type a at standard doses is inherent to the successful treatment of spastic equinus foot in cerebral palsy: short-term neurophysiological and clinical study.
    Frasson E; Dall'ora E; Bordignon M; Brigo F; Tocco P; Primon D; Didonè G; Vicentini S; Fiaschi A; Bertolasi L
    J Child Neurol; 2012 May; 27(5):587-93. PubMed ID: 22114218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of addition of botulinum toxin-A to standardized therapy for dynamic manual skills measured with kinematic aiming tasks in children with spastic hemiplegia.
    Rameckers EA; Duysens J; Speth LA; Vles HJ; Smits-Engelsman BC
    J Rehabil Med; 2010 Apr; 42(4):332-8. PubMed ID: 20461335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Injection frequency of botulinum toxin A for spastic equinus: a randomized clinical trial.
    Hastings-Ison T; Blackburn C; Rawicki B; Fahey M; Simpson P; Baker R; Graham K
    Dev Med Child Neurol; 2016 Jul; 58(7):750-7. PubMed ID: 26589633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upper extremity spasticity in children with cerebral palsy: a randomized, double-blind, placebo-controlled study of the short-term outcomes of treatment with botulinum A toxin.
    Koman LA; Smith BP; Williams R; Richardson R; Naughton M; Griffin L; Evans P
    J Hand Surg Am; 2013 Mar; 38(3):435-46.e1. PubMed ID: 23428186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomechanical transformation of the gastroc-soleus muscle with botulinum toxin A in children with cerebral palsy.
    Boyd RN; Pliatsios V; Starr R; Wolfe R; Graham HK
    Dev Med Child Neurol; 2000 Jan; 42(1):32-41. PubMed ID: 10665973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasonographic evaluation of changes in the muscle architecture of the gastrocnemius with botulinum toxin treatment for lower extremity spasticity in children with cerebral palsy.
    Kawano A; Yanagizono T; Kadouchi I; Umezaki T; Chosa E
    J Orthop Sci; 2018 Mar; 23(2):389-393. PubMed ID: 29146092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of muscle activity and botulinum toxin dilution volume on muscle paralysis.
    Kim HS; Hwang JH; Jeong ST; Lee YT; Lee PK; Suh YL; Shim JS
    Dev Med Child Neurol; 2003 Mar; 45(3):200-6. PubMed ID: 12613778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle histopathology in children with spastic cerebral palsy receiving botulinum toxin type A.
    Valentine J; Stannage K; Fabian V; Ellis K; Reid S; Pitcher C; Elliott C
    Muscle Nerve; 2016 Mar; 53(3):407-14. PubMed ID: 26154631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analgesic effects of botulinum toxin A: a randomized, placebo-controlled clinical trial.
    Barwood S; Baillieu C; Boyd R; Brereton K; Low J; Nattrass G; Graham HK
    Dev Med Child Neurol; 2000 Feb; 42(2):116-21. PubMed ID: 10698329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.